Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QP002 gel single-dose study for pain after unilateral hallux valgus surgery
ChiCTR2300071743Phase 2Recruiting
- Sponsor
- Beijing Jishuitan Hospital
- Start
- May 2023
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of QP002 in postoperative pain (4 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoint: NRS pain intensity score. Started May 2023; status: recruiting.
02
Drugs
QP002
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300071743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071743.